BioElectronics Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
665.50
1,289.90
2,339.60
2,089.70
1,763.80
1,045.90
Cost of Goods Sold (COGS) incl. D&A
447.30
761.50
1,008.90
834.20
767.90
690.70
Gross Income
218.20
528.40
1,330.70
1,255.50
995.80
355.20
SG&A Expense
2,151.80
2,601.80
3,117.20
2,655.70
2,356.10
2,390.80
EBIT
1,933.50
2,073.40
-
1,400.20
1,360.30
2,035.70
Non Operating Income/Expense
125.10
-
3.40
4.80
-
-
Interest Expense
637.20
604.00
667.20
711.30
758.50
952.70
Pretax Income
2,445.60
2,677.30
2,450.20
2,106.70
2,118.80
2,988.30
Consolidated Net Income
2,445.60
2,677.30
2,450.20
2,106.70
2,118.80
2,988.30
Net Income
2,445.60
2,677.30
2,450.20
2,106.70
2,118.80
2,988.30
Net Income After Extraordinaries
2,445.60
2,677.30
2,450.20
2,106.70
2,118.80
2,988.30
Net Income Available to Common
2,445.60
2,677.30
2,450.20
2,106.70
2,118.80
2,988.30
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
-
Basic Shares Outstanding
3,263,120.20
4,836,168.00
8,561,703.60
12,839,985.30
16,978,720.90
19,848,940.40
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
-
Diluted Shares Outstanding
3,263,120.20
4,836,168.00
8,561,703.60
12,839,985.30
16,978,720.90
19,848,940.40
EBITDA
1,917.00
2,056.70
1,775.50
1,397.00
1,358.00
2,033.40

About BioElectronics

View Profile
Address
4539 Metropolitan Court
Frederick Maryland 21704
United States
Employees -
Website http://www.bioelectronicscorp.com
Updated 07/08/2019
BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. Its products include ActiPatch, Allay, Smart Insole, HealFast, and RecoveryRx. The company was founded by Andrew J.